UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 16, 2025
Accession Number: 0001493152-25-001950
Submission Type: POS AM
CIK: 0001106838
Company Name: Sonnet BioTherapeutics Holdings, Inc.
File Number: 333-279095